61 matches.
- BlogsCMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 913 minute read
FDA Releases Laboratory-Developed Tests Final Rule- BlogsIt’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived8 minute read
- PublicationsAdvancing Interoperability and Improving Prior Authorization: No One Said It Would Be Easy!18 minute read
- BlogsLast Call for Comments on the Bipartisan Discussion Draft of the SUSTAIN Act: Shaping 340B for the Future10 minute read
- PublicationsCMS Seeks Stakeholder Feedback About Medicare Transaction Facilitator Services for the Medicare Drug Price Negotiation Program by November 13: Inflation Reduction Act Updates4 minute read
-
Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
- BlogsCMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates11 minute read
- PublicationsState Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law25 minute read
- BlogsTexas Federal Court Issues Fourth Ruling Invalidating Parts of the Administration’s No Surprises Act Regulations3 minute read
- BlogsIndependent Dispute Resolution Process Halted Following the Government's Third Major No Surprises Act-Related Loss in Federal Court4 minute read
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?- BlogsTAKE TWO: CMS’s Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year26 minute read
- PublicationsCMS Releases Its List of 43 Part B Rebatable Drugs for Q3: Inflation Reduction Act Updates7 minute read
- PublicationsManufacturers Must Request Small Biotech Exception by July 3: Inflation Reduction Act Updates4 minute read
- PublicationsCMS Seeks Comment on Initial Guidance for the Part D Manufacturer Discount Program: Inflation Reduction Act Updates2 minute read
- BlogsMore Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate12 minute read
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
- PublicationsCMS Issues an Information Collection Request for the Drug Price Negotiation Process: Inflation Reduction Act Updates3 minute read
- BlogsCMS Forwards Its Health Equity Agenda Through Its Annual Prospective Payment System Rulemaking Process5 minute read
- PublicationsCMS Issues an Information Collection Request on Negotiation Data Elements: Inflation Reduction Act Updates3 minute read
- PublicationsCMS Issues New Guidance on Medicare Drug Price Negotiation Program: Inflation Reduction Act Updates2 minute read
- PublicationsCMS Releases Its List of 27 Part B Rebatable Drugs for Q2 of 2023: Inflation Reduction Act Updates3 minute read
- BlogsComments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 202310 minute read
- EventsHealthXchange Patient Access: Foundation of the Revenue Cycle — Patient Estimates and the No Surprises ActFebruary 21, 20231 minute read
-
2023 Health Policy Outlook
- PublicationsNo Surprises Act: HHS Extends Enforcement Moratorium on Co-Provider & Co-Facility Good Faith Estimates5 minute read
- PublicationsOverview of the CMS Request for Information to Strengthen the Medicare Advantage Program2 minute read
- BlogsFederal District Court Vacates QPA Rebuttable Presumption Provisions of No Surprises Act Regulations4 minute read
- BlogsCMS Releases No Surprises Act State Enforcement Letters4 minute read
-
No Surprises Act: New Rules and Guidance for Stakeholders (Part 2)
-
No Surprises Act: New Rules and Guidance for Stakeholders (Part 1)
-
Getting Ready for the No Surprises Act
- Firm AnnouncementsEpstein Becker Green Reports Telemental Health’s Influence Grows Throughout COVID-19 Pandemic6 minute read
- PublicationsMore Surprises on Surprise Billing: Will Federal or State Law Control?2 minute read
-
No Surprises Act: Considerations for Plans and Providers
- EventsCorporate Counsel Women of Color: Healthcare Trends 20211 minute read
- PublicationsThe No Surprises Act: New and Surprising Challenges for Clinical Laboratories3 minute read
- PublicationsThe No Surprises Act: A Look at the First Round of Federal Regulations on Surprise Billing3 minute read
- PublicationsMore Surprises on Surprise Billing: Will Federal or State Law Control?11 minute read
- PublicationsKey False Claims Act Developments Affecting the Health Care Industry: What We Learned in 2020 & Predictions for What We Can Expect in 20215 minute read
- PublicationsThe No Surprises Act: Implications for Health Plans, Health Care Facilities, and Health Care Providers19 minute read
- PublicationsFinalized HHS Drug Formulary Rebate Rule Faces Uncertain Future Under Biden Administration and Current Legal Challenge20 minute read
- PublicationsLowering Drug Prices with the Anti-Kickback Statute: Future and Impact of HHS Final Rule to Disrupt Drug Formulary Rebates2 minute read
- PublicationsFalse Claims Act Enforcement During the COVID-19 Pandemic and Beyond1 minute read
- Firm AnnouncementsEpstein Becker Green's Annual Telehealth Analysis Reports an Increase in Telemental Health Fraud6 minute read
- BlogsFalse Claims Act Enforcement During the COVID-19 Pandemic and Beyond22 minute read
- PublicationsPresident Trump Signs Executive Orders on Drug Pricing and Domestic Supply Chain Reform22 minute read
- PublicationsINSIGHT: Labs Must Follow Two Kickback Laws During Covid-192 minute read
- PublicationsNew and Pre-Existing Federal Waivers and Flexibilities Available to Health Care Providers During a National Emergency23 minute read
- Media CoverageLaw360's Hottest Firms and Stories Features Health Care FCA Trends Article by Epstein Becker Green Attorneys2 minute read
- PublicationsWhat Health Care FCA Trends Tell Us About the Year Ahead2 minute read
- BlogsDOJ False Claims Act Recoveries FY 2019: Total Collections Rise – Almost 90 Percent Relate to Health Care5 minute read
- BlogsNew Program Integrity Rule Expanding Medicare Revocation and Denial Authorities Takes Effect Today17 minute read
- PublicationsHHS’s Regulatory Sprint to Coordinated Care – Part 2: OIG Issues Long-Awaited Proposed Rules34 minute read
- Firm AnnouncementsEpstein Becker Green Finds Increasing Acceptance of Telehealth Services Among Providers and Legislators8 minute read
- EventsThird Annual Healthcare Law & Compliance Boot Camp for Healthcare Providers: Reforming Health Reform1 minute read
- PublicationsSafeguarding America’s Health System from Sabotage
- PublicationsHealth Reform at the Crossroads: Progress or Peril?
- PublicationsAccountable Care Organization Summit: A White Paper on Findings, Outcomes, and Challenges
- PublicationsThe Management of Type II Diabetes Mellitus in the Face of the Healthcare System and Social Determinants
